NCT Number: NCT02378376
In Vivo Quantification of Short Chain Fatty Acids Production in the Human Colon
During this project the amount of SCFA produced in the colon after consumption of 2 different 13C-labelled wheat fiber fractions will be quantified.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Regular diet with 3 meals a day (minimal 5 times a week)
- BMI between 18.5 and 27 kg/m2
Exclusion criteria
- Calorie restricted diet or other special diet during the study or during the last month prior to the study
- Antibiotics in the month prior to the study
- Former surgeries on the gastrointestinal tract, with the exception of an appendectomy
- use of the following types of medications with effects on the gastrointestinal tract during the last 2 weeks prior to the study (spasmolytica, anti-diarrhea, anti-constipation, probiotics)
- Chronic disease of the gastrointestinal tract such as Crohn's disease, ulcerative colitis, irritable bowel syndrome, chronic constipation, chronic frequent diarrhea, clinically relevant lactose intolerance
- Pregnancy, pregnancy desire or breastfeeding
- Diabetes (type 1 and 2)
- Blood donation in the past 3 months prior to the study
- Abnormal hemoglobin (Hb) levels in blood, men must have a Hb level between 14.0 and 18.0 g / dL and women between 12.0 and 16.0 g / dL
- Participation in studies in the past year in which radiation was used.
Treatment and study plan
Dietary fiber enriched bran
Dietary SupplementPrimary outcomes
-
Quantification of acetate, propionate and butyrate production in the colon after consumption of each wheat derived fiber fraction
Time frame: 2 years
Sponsors and collaborators
Lead sponsor
KU Leuven
Other
Registry information
Official study title
In Vivo Quantification of Short Chain Fatty Acids Production in the Human Colon After Consumption of Different Cereal Fractions.
Important dates
- Study start
- 2013
- Primary completion
- 2014
- Study completion
- 2015
- First posted
- Mar 4, 2015
- Registry last updated
- Mar 4, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Tumor-Derived FGF19
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsAI Chatbot for HPV Vaccine Literacy Among Caregivers in Japan
NCT06702423
Healthy
London, United Kingdom
View Trial DetailsValidation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease
NCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNormative Value for Navicular Drop Test in Older Adults
NCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details